CONTRIBUTION OF ALPHA-INTERFERON (ALPHA-IFN) TO HIV-INDUCED IMMUNOSUPPRESSION

被引:0
|
作者
LACHGAR, A
BIZZINI, B
机构
关键词
HIV INFECTION; IMMUNOSUPPRESSION; ALPHA INTERFERON; INACTIVATION;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In the present investigation we have shown that PBLs taken from HIV-positive patients suppressed T-cell proliferation when cultured for at least 12 days. When infected In vitro with HIV-1, these cells become suppressive after 6 days. PBLs collected from seronegative individuals turned out to be non-suppressive even after prolonged culturing. However, when infected in vitro with HIV they were found to be cytostatic also after 6 days. This anti-immune activity, related to HIV infection, is mediated, at least in part, by alpha IFN, since about 50% of this HIV associated activity could be quenched by alpha IFN antibodies. We also showed that this T-cell cytostasis is associated with CD8(+) cells. In view of a possible use of suppressive cells for T-cell vaccination, we verified that such cellular functions were abolished by aldehyde treatment.
引用
收藏
页码:431 / 437
页数:7
相关论文
共 50 条
  • [41] TREATMENT OF WALDENSTROMS MACROGLOBULINEMIA WITH VERY-LOW DOSES OF ALPHA-INTERFERON
    LEGOUFFE, E
    ROSSI, JF
    LAPORTE, JP
    ISNARD, F
    OZIOL, E
    FABBRO, M
    JANBON, C
    JOURDAN, J
    NAJMAN, A
    LEUKEMIA & LYMPHOMA, 1995, 19 (3-4) : 337 - 342
  • [42] ACUTE-RENAL-FAILURE WITH ALPHA-INTERFERON THERAPY - A CASE-REPORT
    AYUB, A
    ZAFAR, M
    ALHARBI, A
    ELLIS, M
    QUNIBI, W
    MEDICAL SCIENCE RESEARCH, 1993, 21 (03): : 123 - 124
  • [43] TREATMENT OF MALIGNANT PLEURAL MESOTHELIOMA WITH CISPLATIN, MITOMYCIN-C AND ALPHA-INTERFERON
    TANSAN, S
    EMRI, S
    SELCUK, T
    KOC, Y
    HESKETH, P
    HEEREN, T
    MCCAFFREY, R
    BARIS, YI
    ONCOLOGY, 1994, 51 (04) : 348 - 351
  • [44] Development of arthritis and hypothyroidism during alpha-interferon therapy for chronic hepatitis C
    Pittau, E
    Bogliolo, A
    Tinti, A
    Mela, Q
    Ibba, G
    Salis, G
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1997, 15 (04) : 415 - 419
  • [45] COMBINED ORAL ISOPRINOSINE INTRAVENTRICULAR ALPHA-INTERFERON THERAPY FOR SUBACUTE SCLEROSING PANENCEPHALITIS
    GASCON, G
    YAMANI, S
    CROWELL, J
    STIGSBY, B
    NESTER, M
    KANAAN, I
    JALLU, A
    BRAIN & DEVELOPMENT, 1993, 15 (05) : 346 - 355
  • [46] Nasopharyngeal carcinoma: An EBV-associated tumour not significantly influenced by HIV-induced immunosuppression
    Melbye, M
    Cote, TR
    West, D
    Kessler, L
    Biggar, RJ
    Lemp, G
    Singleton, J
    Young, J
    Kerndt, P
    Deapen, D
    Ginzberg, M
    AntonCulver, H
    Lieb, S
    Hopkins, R
    Williams, B
    Liff, J
    Morgan, D
    Parkin, W
    BRITISH JOURNAL OF CANCER, 1996, 73 (08) : 995 - 997
  • [47] Focal segmental glomerulosclerosis with acute renal failure associated with alpha-interferon therapy
    Coroneos, E
    Petrusevska, G
    Varghese, F
    Truong, LD
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 28 (06) : 888 - 892
  • [48] REPEATED COURSES OF ALPHA-INTERFERON FOR TREATMENT OF CHRONIC HEPATITIS TYPE-B
    JANSSEN, HLA
    SCHALM, SW
    BERK, L
    DEMAN, RA
    HEIJTINK, RA
    JOURNAL OF HEPATOLOGY, 1993, 17 : S47 - S51
  • [49] BIOAVAILABILITY OF PULMONARY DELIVERED PEPTIDES AND PROTEINS - ALPHA-INTERFERON, CALCITONINS AND PARATHYROID HORMONES
    PATTON, JS
    TRINCHERO, P
    PLATZ, RM
    JOURNAL OF CONTROLLED RELEASE, 1994, 28 (1-3) : 79 - 85
  • [50] EFFICACY OF ALPHA-INTERFERON AND HYDROXYUREA IN LATE-PHASE REFRACTORY MYELOPROLIFERATIVE DISEASE
    LITAM, PP
    LANDAW, SA
    ZAMKOFF, KW
    HAEMATOLOGIA, 1994, 26 (02) : 87 - 90